Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate

European Journal of Neuroscience

Volumn 32, Issue 4, 2010, Pages 668-676

  Michaelides, Michael ^a,b   Pascau, Javier ^c   Gispert, Juan Domingo ^d   Delis, Foteini ^e   Grandy, David K ^f   Wang, Gene Jack ^e   Desco, Manuel ^c   Rubinstein, Marcelo ^g   Volkow, Nora D ^e   Thanos, Panayotis K ^a,d,e  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d Institut d'Alta Tecnologia   (Spain)

^e NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

2 18F fluoro 2 deoxy d glucose; Attention deficit hyperactivity disorder; Mice; Micro positron emission tomography; Positron emission tomography

Indexed keywords

DOPAMINE 4 RECEPTOR; FLUORODEOXYGLUCOSE F 18; METHYLPHENIDATE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN METABOLISM; CEREBELLUM; CEREBELLUM VERMIS; CONTROLLED STUDY; GENE ACTIVATION; GENE DELETION; GLUCOSE BRAIN LEVEL; IMAGE ANALYSIS; MALE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; REST;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CEREBELLUM; CHILD; DOPAMINE UPTAKE INHIBITORS; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MALE; METHYLPHENIDATE; MICE; MICE, KNOCKOUT; POLYMORPHISM, GENETIC; POSITRON-EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; RECEPTORS, DOPAMINE D4;

EID: 77955753194     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2010.07319.x     Document Type: Article

References (95)

1. 11C-raclopride binding in the rat brain measured with the microPET R4: effects of scatter correction and tracer specific activity. J. Nucl. Med., 44, 815 822.
2. Anderson, C.M., Polcari, A., Lowen, S.B., Renshaw, P.F. Teicher, M.H. (2002) Effects of methylphenidate on functional magnetic resonance relaxometry of the cerebellar vermis in boys with ADHD. Am. J. Psychiatry, 159, 1322 1328.
3. Anderson, C.M., Lowen, S.B. Renshaw, P.F. (2006) Emotional task-dependent low-frequency fluctuations and methylphenidate: Wavelet scaling analysis of 1/f-type fluctuations in fMRI of the cerebellar vermis. J. Neurosci. Methods, 151, 52 61.
4. Andreasen, N.C., O'Leary, D.S., Arndt, S., Cizadlo, T., Hurtig, R., Rezai, K., Watkins, G.L., Ponto, L.L. Hichwa, R.D. (1995) Short-term and long-term verbal memory: a positron emission tomography study. Proc. Natl Acad. Sci. USA, 92, 5111 5115.
5. Ariano, M.A., Wang, J., Noblett, K.L., Larson, E.R. Sibley, D.R. (1997) Cellular distribution of the rat D4 dopamine receptor protein in the CNS using anti-receptor antisera. Brain Res., 752, 26 34. (Pubitemid 27143894)
6. Aron, A.R., Robbins, T.W. Poldrack, R.A. (2004) Inhibition and the right inferior frontal cortex. Trends Cogn. Sci., 8, 170 177.
7. Barili, P., Bronzetti, E., Ricci, A., Zaccheo, D. Amenta, F. (2000) Microanatomical localization of dopamine receptor protein immunoreactivity in the rat cerebellar cortex. Brain Res., 854, 130 138.
8. Barkley, R.A., Grodzinsky, G. DuPaul, G.J. (1992) Frontal lobe functions in attention deficit disorder with and without hyperactivity: a review and research report. J. Abnorm. Child Psychol., 20, 163 188.
9. Bartus, R.T. Levere, T.E. (1977) Frontal decortication in rhesus monkeys: a test of the interference hypothesis. Brain Res., 119, 233 248.
10. Berquin, P.C., Giedd, J.N., Jacobsen, L.K., Hamburger, S.D., Krain, A.L., Rapoport, J.L. Castellanos, F.X. (1998) Cerebellum in attention-deficit hyperactivity disorder: a morphometric MRI study. Neurology, 50, 1087 1093.
11. Birrell, J.M. Brown, V.J. (2000) Medial frontal cortex mediates perceptual attentional set shifting in the rat. J. Neurosci., 20, 4320 4324.
12. Borghammer, P., Cumming, P., Aanerud, J., Forster, S. Gjedde, A. (2009) Subcortical elevation of metabolism in Parkinson's disease - a critical reappraisal in the context of global mean normalization. Neuroimage, 47, 1514 1521.
13. Braszko, J.J. (2009) Dopamine D4 receptor antagonist L745,870 abolishes cognitive effects of intracerebroventricular angiotensin IV and des-Phe(6)-Ang IV in rats. Eur. Neuropsychopharmacol., 19, 85 91.
14. Braszko, J.J. (2010) Participation of D(1-4) dopamine receptors in the pro-cognitive effects of angiotensin IV and des-Phe(6) angiotensin IV. Neurosci. Biobehav. Rev., 34, 343 350.
15. Brennan, A.R. Arnsten, A.F. (2008) Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function. Ann. N Y Acad. Sci., 1129, 236 245.
16. Bush, G., Frazier, J.A., Rauch, S.L., Seidman, L.J., Whalen, P.J., Jenike, M.A., Rosen, B.R. Biederman, J. (1999) Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biol. Psychiatry, 45, 1542 1552.
17. Casey, B.J., Castellanos, F.X., Giedd, J.N., Marsh, W.L., Hamburger, S.D., Schubert, A.B., Vauss, Y.C., Vaituzis, A.C., Dickstein, D.P., Sarfatti, S.E. Rapoport, J.L. (1997) Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry, 36, 374 383.
18. Castellanos, F.X., Giedd, J.N., Marsh, W.L., Hamburger, S.D., Vaituzis, A.C., Dickstein, D.P., Sarfatti, S.E., Vauss, Y.C., Snell, J.W., Lange, N., Kaysen, D., Krain, A.L., Ritchie, G.F., Rajapakse, J.C. Rapoport, J.L. (1996) Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch. Gen. Psychiatry, 53, 607 616. (Pubitemid 26240863)
19. Castellanos, F.X., Giedd, J.N., Berquin, P.C., Walter, J.M., Sharp, W., Tran, T., Vaituzis, A.C., Blumenthal, J.D., Nelson, J., Bastain, T.M., Zijdenbos, A., Evans, A.C. Rapoport, J.L. (2001) Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry, 58, 289 295.
20. Cheon, K.A., Kim, B.N. Cho, S.C. (2007) Association of 4-repeat allele of the dopamine D4 receptor gene exon III polymorphism and response to methylphenidate treatment in Korean ADHD children. Neuropsychopharmacology, 32, 1377 1383.
21. Desmond, J.E., Gabrieli, J.D. Glover, G.H. (1998) Dissociation of frontal and cerebellar activity in a cognitive task: evidence for a distinction between selection and search. Neuroimage, 7, 368 376.
22. Dulawa, S.C., Grandy, D.K., Low, M.J., Paulus, M.P. Geyer, M.A. (1999) Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J. Neurosci., 19, 9550 9556.
23. Durston, S., Fossella, J.A., Casey, B.J., Hulshoff Pol, H.E., Galvan, A., Schnack, H.G., Steenhuis, M.P., Minderaa, R.B., Buitelaar, J.K., Kahn, R.S. van Engeland, H. (2005) Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls. Mol. Psychiatry., 10, 678 685.
24. Falzone, T.L., Gelman, D.M., Young, J.I., Grandy, D.K., Low, M.J. Rubinstein, M. (2002) Absence of dopamine D4 receptors results in enhanced reactivity to unconditioned, but not conditioned, fear. Eur. J. Neurosci., 15, 158 164.
25. Fergason, J.H. (2000) National Institutes of Health Consensus Development Conference Statement: diagnosis and treatment of attention-deficit/ hyperactivity disorder (ADHD). J. Am. Acad. Child Adolesc. Psychiatry, 39, 182 193.
26. Fuster, J.M. (2001) The prefrontal cortex - an update: time is of the essence. Neuron, 30, 319 333.
27. Gatley, S.J., Pan, D., Chen, R., Chaturvedi, G. Ding, Y.S. (1996) Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sci., 58, 231 239. (Pubitemid 126352709)
28. Giedd, J.N., Blumenthal, J., Molloy, E. Castellanos, F.X. (2001) Brain imaging of attention deficit/hyperactivity disorder. Ann. N Y Acad. Sci., 931, 33 49.
29. Glaser, P.E., Surgener, S.P., Grondin, R., Gash, C.R., Palmer, M., Castellanos, F.X. Gerhardt, G.A. (2006) Cerebellar neurotransmission in attention-deficit/hyperactivity disorder: does dopamine neurotransmission occur in the cerebellar vermis? J. Neurosci. Methods, 151, 62 67.
30. Godefroy, O., Lhullier, C. Rousseaux, M. (1996) Non-spatial attention disorders in patients with frontal or posterior brain damage. Brain, 119 Pt 1 191 202.
31. Goldman-Rakic, P.S. (1996) The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive. Philos. Trans. R. Soc. Lond. B Biol. Sci., 351, 1445 1453.
32. Hamarman, S., Fossella, J., Ulger, C., Brimacombe, M. Dermody, J. (2004) Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: a pharmacogenetic study. J. Child Adolesc. Psychopharmacol., 14, 564 574.
33. Himelstein, J., Newcorn, J.H. Halperin, J.M. (2000) The neurobiology of attention-deficit hyperactivity disorder. Front. Biosci., 5, D461 D478.
34. Hoshi, E., Tremblay, L., Feger, J., Carras, P.L. Strick, P.L. (2005) The cerebellum communicates with the basal ganglia. Nat. Neurosci., 8, 1491 1493.
35. Houk, J.C. Wise, S.P. (1995) Distributed modular architectures linking basal ganglia, cerebellum, and cerebral cortex: their role in planning and controlling action. Cereb. Cortex, 5, 95 110.
36. Ichinohe, N., Mori, F. Shoumura, K. (2000) A di-synaptic projection from the lateral cerebellar nucleus to the laterodorsal part of the striatum via the central lateral nucleus of the thalamus in the rat. Brain Res., 880, 191 197.
37. Itami, S. Uno, H. (2002) Orbitofrontal cortex dysfunction in attention-deficit hyperactivity disorder revealed by reversal and extinction tasks. Neuroreport, 13, 2453 2457.
38. Kuczenski, R. Segal, D.S. (1997) Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J. Neurochem., 68, 2032 2037. (Pubitemid 27176139)
39. Kung, M.P., Choi, S.R., Hou, C., Zhuang, Z.P., Foulon, C. Kung, H.F. (2004) Selective binding of 2-[125I]iodo-nisoxetine to norepinephrine transporters in the brain. Nucl. Med. Biol., 31, 533 541.
40. LaHoste, G.J., Swanson, J.M., Wigal, S.B., Glabe, C., Wigal, T., King, N. Kennedy, J.L. (1996) Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol. Psychiatry., 1, 121 124.
41. Leiner, H.C., Leiner, A.L. Dow, R.S. (1989) Reappraising the cerebellum: what does the hindbrain contribute to the forebrain? Behav. Neurosci., 103, 998 1008.
42. Li, Q., Lu, G., Antonio, G.E., Mak, Y.T., Rudd, J.A., Fan, M. Yew, D.T. (2007) The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain. Neurochem. Int., 50, 848 857.
43. 18F]-fluoro-D-glucose cerebral uptake in rodents through time. Nucl. Med. Biol., 33, 71 79.
44. Matochik, J.A., Nordahl, T.E., Gross, M., Semple, W.E., King, A.C., Cohen, R.M. Zametkin, A.J. (1993) Effects of acute stimulant medication on cerebral metabolism in adults with hyperactivity. Neuropsychopharmacology, 8, 377 386.
45. Matochik, J.A., Liebenauer, L.L., King, A.C., Szymanski, H.V., Cohen, R.M. Zametkin, A.J. (1994) Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment. Am. J. Psychiatry, 151, 658 664.
46. Mehta, M.A., Owen, A.M., Sahakian, B.J., Mavaddat, N., Pickard, J.D. Robbins, T.W. (2000) Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J. Neurosci., 20, RC65.
47. Melchitzky, D.S. Lewis, D.A. (2000) Tyrosine hydroxylase- and dopamine transporter-immunoreactive axons in the primate cerebellum. Evidence for a lobular- and laminar-specific dopamine innervation. Neuropsychopharmacology, 22, 466 472.
48. Middleton, F.A. Strick, P.L. (2001) Cerebellar projections to the prefrontal cortex of the primate. J. Neurosci., 21, 700 712.
49. 11C]FLB 457 PET. J. Cereb. Blood Flow Metab., 27, 369 377.
50. Monuteaux, M.C., Seidman, L.J., Faraone, S.V., Makris, N., Spencer, T., Valera, E., Brown, A., Bush, G., Doyle, A.E., Hughes, S., Helliesen, M., Mick, E. Biederman, J. (2008) A preliminary study of dopamine D4 receptor genotype and structural brain alterations in adults with ADHD. Am. J. Med. Genet. B Neuropsychiatr. Genet., 147B, 1436 1441.
51. Mostofsky, S.H., Reiss, A.L., Lockhart, P. Denckla, M.B. (1998) Evaluation of cerebellar size in attention-deficit hyperactivity disorder. J. Child Neurol., 13, 434 439.
52. Mrzljak, L., Bergson, C., Pappy, M., Huff, R., Levenson, R. Goldman-Rakic, P.S. (1996) Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature, 381, 245 248.
53. NAS & NRC (1996) Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington D.C.
54. Nieoullon, A., Cheramy, A. Glowinski, J. (1978) Release of dopamine in both caudate nuclei and both substantia nigrae in response to unilateral stimulation of cerebellar nuclei in the cat. Brain Res., 148, 143 152. (Pubitemid 8344489)
55. Oak, J.N., Oldenhof, J. Van Tol, H.H.M. (2000) The dopamine D4 receptor: one decade of research. Eur. J. Pharmacol., 405, 303 327.
56. Pary, R., Lewis, S., Matuschka, P.R., Rudzinskiy, P., Safi, M. Lippmann, S. (2002) Attention deficit disorder in adults. Ann. Clin. Psychiatry, 14, 105 111.
57. Pascau, J., Gispert, J.D., Michaelides, M., Thanos, P.K., Volkow, N.D., Vaquero, J.J., Soto-Montenegro, M.L. Desco, M. (2009) Automated method for small-animal PET image registration with intrinsic validation. Mol Imaging Biol, 11, 107 113.
58. Patrick, K.S., Caldwell, R.W., Ferris, R.M. Breese, G.R. (1987) Pharmacology of the enantiomers of threo-methylphenidate. J. Pharmacol. Exp. Ther., 241, 152 158.
59. Pontieri, F.E., Mainero, C., La Riccia, M., Passarelli, F. Orzi, F. (1995) Functional correlates of repeated administration of cocaine and apomorphine in the rat. Eur. J. Pharmacol., 284, 205 209.
60. Rapoport, M., van Reekum, R. Mayberg, H. (2000) The role of the cerebellum in cognition and behavior: a selective review. J. Neuropsychiatry Clin. Neurosci., 12, 193 198.
61. Rubia, K., Overmeyer, S., Taylor, E., Brammer, M., Williams, S.C., Simmons, A. Bullmore, E.T. (1999) Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI. Am. J. Psychiatry, 156, 891 896.
62. Rubinstein, M., Phillips, T.J., Bunzow, J.R., Falzone, T.L., Dziewczapolski, G., Zhang, G., Fang, Y., Larson, J.L., McDougall, J.A., Chester, J.A., Saez, C., Pugsley, T.A., Gershanik, O., Low, M.J. Grandy, D.K. (1997) Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell, 90, 991 1001.
63. Rubinstein, M., Cepeda, C., Hurst, R.S., Flores-Hernandez, J., Ariano, M.A., Falzone, T.L., Kozell, L.B., Meshul, C.K., Bunzow, J.R., Low, M.J., Levine, M.S. Grandy, D.K. (2001) Dopamine D4 receptor-deficient mice display cortical hyperexcitability. J. Neurosci., 21, 3756 3763.
64. Schiffer, W.K., Mirrione, M.M. Dewey, S.L. (2007) Optimizing experimental protocols for quantitative behavioral imaging with 18F-FDG in rodents. J. Nucl. Med., 48, 277 287.
65. Schmahmann, J.D. (2004) Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. J. Neuropsychiatry Clin. Neurosci., 16, 367 378.
66. Schweitzer, J.B., Faber, T.L., Grafton, S.T., Tune, L.E., Hoffman, J.M. Kilts, C.D. (2000) Alterations in the functional anatomy of working memory in adult attention deficit hyperactivity disorder. Am. J. Psychiatry, 157, 278 280.
67. Schweitzer, J.B., Lee, D.O., Hanford, R.B., Tagamets, M.A., Hoffman, J.M., Grafton, S.T. Kilts, C.D. (2003) A positron emission tomography study of methylphenidate in adults with ADHD: alterations in resting blood flow and predicting treatment response. Neuropsychopharmacology, 28, 967 973.
68. Seeger, G., Schloss, P. Schmidt, M.H. (2001) Functional polymorphism within the promotor of the serotonin transporter gene is associated with severe hyperkinetic disorders. Mol. Psychiatry., 6, 235 238.
69. Snider, R.S., Maiti, A. Snider, S.R. (1976) Cerebellar pathways to ventral midbrain and nigra. Exp. Neurol., 53, 714 728.
70. Sowell, E.R., Thompson, P.M., Welcome, S.E., Henkenius, A.L., Toga, A.W. Peterson, B.S. (2003) Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder. Lancet, 362, 1699 1707.
71. Strazielle, C., Lalonde, R., Hebert, C. Reader, T.A. (1999) Regional brain distribution of noradrenaline uptake sites, and of alpha1-alpha2- and beta-adrenergic receptors in PCD mutant mice: a quantitative autoradiographic study. Neuroscience, 94, 287 304.
72. Sunohara, G.A., Roberts, W., Malone, M., Schachar, R.J., Tannock, R., Basile, V.S., Wigal, T., Wigal, S.B., Schuck, S., Moriarty, J., Swanson, J.M., Kennedy, J.L. Barr, C.L. (2000) Linkage of the dopamine D4 receptor gene and attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry, 39, 1537 1542.
73. Swanson, J.M., Sunohara, G.A., Kennedy, J.L., Regino, R., Fineberg, E., Wigal, T., Lerner, M., Williams, L., LaHoste, G.J. Wigal, S. (1998) Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol. Psychiatry., 3, 38 41.
74. Tahir, E., Yazgan, Y., Cirakoglu, B., Ozbay, F., Waldman, I. Asherson, P.J. (2000) Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Mol. Psychiatry., 5, 396 404.
75. Tan, S., Hermann, B. Borrelli, E. (2003) Dopaminergic mouse mutants: investigating the roles of the different dopamine receptor subtypes and the dopamine transporter. Int. Rev. Neurobiol., 54, 145 197. (Pubitemid 44961978)
76. Tarazi, F.I. Baldessarini, R.J. (1999) Dopamine D4 receptors: significance for molecular psychiatry at the millennium. Mol. Psychiatry., 4, 529 538.
77. Teicher, M.H., Ito, Y., Glod, C.A. Barber, N.I. (1996) Objective measurement of hyperactivity and attentional problems in ADHD. J. Am. Acad. Child Adolesc. Psychiatry, 35, 334 342.
78. Terwilliger, J.D. Ott, J. (1992) A haplotype-based 'haplotype relative risk' approach to detecting allelic associations. Hum. Hered., 42, 337 346.
79. Thanos, P.K., Michaelides, M., Benveniste, H., Wang, G.J. Volkow, N.D. (2008a) The effects of cocaine on regional brain glucose metabolism is attenuated in dopamine transporter knockout mice. Synapse, 62, 319 324.
80. Thanos, P.K., Michaelides, M., Gispert, J.-D., Pascau, J., Soto-Montenegro, M.L., Desco, M., Wang, R., Wang, G.-J. Volkow, N.D. (2008b) Differences in response to food stimuli in a rat model of obesity: in-vivo assessment of brain glucose metabolism. Int. J. Obes., 32, 1171 1179.
81. Thanos, P., Bermeo, C., Rubinstein, M., Suchland, K., Wang, G., Grandy, D. Volkow, N. (2010) Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine. J Psychopharm., 24, 897 904.
82. Thomas, T.C., Kruzich, P.J., Joyce, B.M., Gash, C.R., Suchland, K., Surgener, S.P., Rutherford, E.C., Grandy, D.K., Gerhardt, G.A. Glaser, P.E. (2007) Dopamine D4 receptor knockout mice exhibit neurochemical changes consistent with decreased dopamine release. J. Neurosci. Methods, 166, 306 314.
83. 2O PET study in healthy volunteers. Hum. Brain Mapp., 28, 625 635.
84. Vaidya, C.J., Austin, G., Kirkorian, G., Ridlehuber, H.W., Desmond, J.E., Glover, G.H. Gabrieli, J.D. (1998) Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc. Natl Acad. Sci. USA, 95, 14494 14499.
85. Volkow, N.D., Levy, A., Brodie, J.D., Wolf, A.P., Cancro, R., Van Gelder, P. Henn, F. (1992) Low cerebellar metabolism in medicated patients with chronic schizophrenia. Am. J. Psychiatry, 149, 686 688.
86. Volkow, N.D., Wang, G.-J., Fowler, J.S., Logan, J., Angrist, B., Hitzemann, R., Lieberman, J. Pappas, N. (1997a) Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. Am. J. Psychiatry, 154, 50 55.
87. Volkow, N.D., Wang, G., Fowler, J.S., Logan, J., Gerasimov, M., Maynard, L., Ding, Y., Gatley, S.J., Gifford, A. Franceschi, D. (2001) Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J. Neurosci., 21, RC121.
88. Volkow, N.D., Wang, G.J., Fowler, J.S. Ding, Y.S. (2005) Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder. Biol. Psychiatry, 57, 1410 1415.
89. Volkow, N.D., Fowler, J.S., Wang, G.J., Telang, F., Logan, J., Wong, C., Ma, J., Pradhan, K., Benveniste, H. Swanson, J.M. (2008) Methylphenidate decreased the amount of glucose needed by the brain to perform a cognitive task. PLoS ONE, 3, e2017.
90. Wang, H.D., Stanwood, G.D., Grandy, D.K. Deutch, A.Y. (2009) Dystrophic dendrites in prefrontal cortical pyramidal cells of dopamine D1 and D2 but not D4 receptor knockout mice. Brain Res., 1300, 58 64.
91. Wedzony, K., Chocyk, A., Mackowiak, M., Fijal, K. Czyrak, A. (2000) Cortical localization of dopamine D4 receptors in the rat brain - immunocytochemical study. J. Physiol. Pharmacol., 51, 205 221.
92. Wilens, T.E. Biederman, J. (1992) The stimulants. Psychiatr. Clin. North Am., 15, 191 222.
93. Woolley, M.L., Waters, K.A., Gartlon, J.E., Lacroix, L.P., Jennings, C., Shaughnessy, F., Ong, A., Pemberton, D.J., Harries, M.H., Southam, E., Jones, D.N. Dawson, L.A. (2009) Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat. Psychopharmacology (Berl), 202, 343 354.
94. Zametkin, A.J., Nordahl, T.E., Gross, M., King, A.C., Semple, W.E., Rumsey, J., Hamburger, S. Cohen, R.M. (1990) Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N. Engl. J. Med., 323, 1361 1366.
95. Zhang, K., Grady, C.J., Tsapakis, E.M., Andersen, S.L., Tarazi, F.I. Baldessarini, R.J. (2004) Regulation of working memory by dopamine D4 receptor in rats. Neuropsychopharmacology, 29, 1648 1655.